Elizabeth Hall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth Hall has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- David Farabee
Department of Population Health, New York University Grossman School of Medicine, New York, USA
2 shared publications Michael L. Prendergast
University of California, Los Angeles
2 shared publicationsMichael Prendergast
UCLA Integrated Substance Abuse Programs, NPI—Semel Institute for Neuroscience, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA 90025, USA
2 shared publicationsUmme Warda
University of California, Los Angeles
2 shared publications- Adeline Nyamathi
University of California Irvine, USA
1 shared publication Barbara Leake
School of Nursing , University of California, Los Angeles , Los Angeles , California , USA
1 shared publication
Latest Publications
- Open Access
- 17 February 2014
- Published by Taylor & Francis in Journal of Offender Rehabilitation
- Vol. 53 (2) , 95-115
Predictors of High Level of Hostility Among Homeless Men on Parole
High levels of hostility present a formidable challenge among homeless ex-offenders. This cross-sectional study assessed correlates of high levels of hostility using baseline data collected on recently-released male parolees (n =472; age 18 – 60) participating in a randomized trial focused on prevention of illicit drug use and recidivism. Predictors of high levels of hostility included greater depressive symptomatology, lower self-esteem, having a mother who was treated for alcohol/drugs, belonging to a gang, more tangible support, having used methamphetamine and having a history of cognitive difficulties. These findings highlight the need to understand predictors of hostility among recently released homeless men and how these predictors may relate to recidivism. Research implications are discussed, as these findings will shape future nurse-led harm reduction and community-based interventions.
- 17 February 2014
- Published by Taylor & Francis in Journal of Offender Rehabilitation
- Vol. 53 (2) , 95-115
Open AccessPredictors of High Level of Hostility Among Homeless Men on Parole
High levels of hostility present a formidable challenge among homeless ex-offenders. This cross-sectional study assessed correlates of high levels of hostility using baseline data collected on recently-released male parolees (n =472; age 18 – 60) participating in a randomized trial focused on prevention of illicit drug use and recidivism. Predictors of high levels of hostility included greater depressive symptomatology, lower self-esteem, having a mother who was treated for alcohol/drugs, belonging to a gang, more tangible support, having used methamphetamine and having a history of cognitive difficulties. These findings highlight the need to understand predictors of hostility among recently released homeless men and how these predictors may relate to recidivism. Research implications are discussed, as these findings will shape future nurse-led harm reduction and community-based interventions.
- 1 January 2012
- Published by SAGE Publications in Substance Abuse
- Vol. 33 (1) , 9-18
Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions
Medication-assisted treatment (MAT) is underutilized in the treatment of drug-dependent, criminal justice populations. This study surveyed criminal justice agencies affiliated with the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) to assess use of MAT and factors influencing use of MAT. A convenience sample (N = 50) of criminal justice agency respondents (e.g., jails, prisons, parole/probation, and drug courts) completed a survey on MAT practices and attitudes. Pregnant women and individuals experiencing withdrawal were most likely to receive MAT for opiate dependence in jail or prison, whereas those reentering the community from jail or prison were the least likely to receive MAT. Factors influencing use of MAT included criminal justice preferences for drug-free treatment, limited knowledge of the benefits of MAT, security concerns, regulations prohibiting use of MAT for certain agencies, and lack of qualified medical staff. Differences across agency type in the factors influencing use and perceptions of MAT were also examined. MAT use is largely limited to detoxification and maintenance of pregnant women in criminal justice settings. Use of MAT during the community reentry period is minimal. Addressing inadequate knowledge and negative attitudes about MAT may increase its adoption, but better linkages to community pharmacotherapy during the reentry period might overcome other issues, including security, liability, staffing, and regulatory concerns. The CJ-DATS collaborative MAT implementation study to address inadequate knowledge, attitudes, and linkage will be described.
- 1 January 2012
- Published by SAGE Publications in Substance Abuse
- Vol. 33 (1) , 9-18
Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions
Medication-assisted treatment (MAT) is underutilized in the treatment of drug-dependent, criminal justice populations. This study surveyed criminal justice agencies affiliated with the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) to assess use of MAT and factors influencing use of MAT. A convenience sample (N = 50) of criminal justice agency respondents (e.g., jails, prisons, parole/probation, and drug courts) completed a survey on MAT practices and attitudes. Pregnant women and individuals experiencing withdrawal were most likely to receive MAT for opiate dependence in jail or prison, whereas those reentering the community from jail or prison were the least likely to receive MAT. Factors influencing use of MAT included criminal justice preferences for drug-free treatment, limited knowledge of the benefits of MAT, security concerns, regulations prohibiting use of MAT for certain agencies, and lack of qualified medical staff. Differences across agency type in the factors influencing use and perceptions of MAT were also examined. MAT use is largely limited to detoxification and maintenance of pregnant women in criminal justice settings. Use of MAT during the community reentry period is minimal. Addressing inadequate knowledge and negative attitudes about MAT may increase its adoption, but better linkages to community pharmacotherapy during the reentry period might overcome other issues, including security, liability, staffing, and regulatory concerns. The CJ-DATS collaborative MAT implementation study to address inadequate knowledge, attitudes, and linkage will be described.
- 1 June 2011
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 40 (4) , 336-348
The relative effectiveness of women-only and mixed-gender treatment for substance-abusing women
- 1 June 2011
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 40 (4) , 336-348
The relative effectiveness of women-only and mixed-gender treatment for substance-abusing women
- 31 July 2009
- Published by SAGE Publications in Criminal Justice and Behavior
- Vol. 36 (9) , 935-953
Reinforcing Abstinence and Treatment Participation Among Offenders in a Drug Diversion Program
This study assessed a 26-week voucher-based intervention to reinforce abstinence and participation in treatment-related activities among substance-abusing offenders court referred to outpatient treatment under drug diversion legislation (California’s Substance Abuse and Crime Prevention Act). Standard treatment consisted of criminal justice supervision and an evidence-based model for treating stimulant abuse. Participants were randomly assigned to four groups, standard treatment (ST) only, ST plus vouchers for testing negative, ST plus vouchers for performing treatment plan activities, and ST plus vouchers for testing negative and/or performing treatment plan activities. Results indicate that voucher-based reinforcement of negative urines and of treatment plan tasks (using a flat reinforcement schedule) showed no statistically significant effects on measures of retention or drug use relative to the standard treatment protocol. It is likely that punishment and reinforcement operating within the criminal justice context had a stronger impact on participants’ treatment retention and drug use than the relatively low-value vouchers awarded as part of the treatment protocol.
- 31 July 2009
- Published by SAGE Publications in Criminal Justice and Behavior
- Vol. 36 (9) , 935-953
Reinforcing Abstinence and Treatment Participation Among Offenders in a Drug Diversion Program
This study assessed a 26-week voucher-based intervention to reinforce abstinence and participation in treatment-related activities among substance-abusing offenders court referred to outpatient treatment under drug diversion legislation (California’s Substance Abuse and Crime Prevention Act). Standard treatment consisted of criminal justice supervision and an evidence-based model for treating stimulant abuse. Participants were randomly assigned to four groups, standard treatment (ST) only, ST plus vouchers for testing negative, ST plus vouchers for performing treatment plan activities, and ST plus vouchers for testing negative and/or performing treatment plan activities. Results indicate that voucher-based reinforcement of negative urines and of treatment plan tasks (using a flat reinforcement schedule) showed no statistically significant effects on measures of retention or drug use relative to the standard treatment protocol. It is likely that punishment and reinforcement operating within the criminal justice context had a stronger impact on participants’ treatment retention and drug use than the relatively low-value vouchers awarded as part of the treatment protocol.
- 1 September 2008
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 35 (2) , 125-136
Use of vouchers to reinforce abstinence and positive behaviors among clients in a drug court treatment program
- 1 September 2008
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 35 (2) , 125-136
Use of vouchers to reinforce abstinence and positive behaviors among clients in a drug court treatment program
- 1 April 2007
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 32 (3) , 291-300
Organizational characteristics of drug abuse treatment programs for offenders
- 1 April 2007
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 32 (3) , 291-300
Organizational characteristics of drug abuse treatment programs for offenders
- 1 January 2003
- Published by Wiley in Law & Policy
- Vol. 25 (1) , 63-82
Is In‐Prison Treatment Enough? A Cost‐Effectiveness Analysis of Prison‐Based Treatment and Aftercare Services for Substance‐Abusing Offenders
This study performed a cost‐effectiveness analysis (CEA) of the Amity in‐prison Therapeutic Community (TC) and Vista aftercare programs for criminal offenders in California. For the average treatment participant, the cost of treatment was $4,112, which led to approximately fifty‐one fewer days incarcerated (36% less) than the average individual in the control group. This implies that, for the average offender, treatment reduced recidivism at a cost of $80 per incarceration day. For participants who received both in‐prison treatment and aftercare services, an additional day of incarceration was avoided at a cost of $51 per day relative to those that received in‐prison treatment only.
- 1 January 2003
- Published by Wiley in Law & Policy
- Vol. 25 (1) , 63-82
Is In‐Prison Treatment Enough? A Cost‐Effectiveness Analysis of Prison‐Based Treatment and Aftercare Services for Substance‐Abusing Offenders
This study performed a cost‐effectiveness analysis (CEA) of the Amity in‐prison Therapeutic Community (TC) and Vista aftercare programs for criminal offenders in California. For the average treatment participant, the cost of treatment was $4,112, which led to approximately fifty‐one fewer days incarcerated (36% less) than the average individual in the control group. This implies that, for the average offender, treatment reduced recidivism at a cost of $80 per incarceration day. For participants who received both in‐prison treatment and aftercare services, an additional day of incarceration was avoided at a cost of $51 per day relative to those that received in‐prison treatment only.
- 1 January 2001
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 36 (3) , 273-299
A SELF-ADMINISTERED INSTRUMENT FOR ASSESSING THERAPEUTIC APPROACHES OF DRUG-USER TREATMENT COUNSELORS
In this article we describe the development and psychometric properties of a self-administered instrument for assessing drug-user treatment counselors' therapeutic approaches such as psychodynamic ...
- 1 January 2001
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 36 (3) , 273-299
A SELF-ADMINISTERED INSTRUMENT FOR ASSESSING THERAPEUTIC APPROACHES OF DRUG-USER TREATMENT COUNSELORS
In this article we describe the development and psychometric properties of a self-administered instrument for assessing drug-user treatment counselors' therapeutic approaches such as psychodynamic ...